timothy sykes logo
FIGS Stock Surges After Big Earnings Beat And Upgraded Outlook Thumbnail

FIGS Stock Surges After Big Earnings Beat And Upgraded Outlook

TIM SYKESUPDATED AUG. 9, 2026, 10:08 AM ET
Reviewed by Bryce Tuoheyand Fact-checked by Matt Monaco

FIGS Inc. stocks have been trading up by 28.71 percent, propelled by upbeat news signaling strengthening demand and investor confidence.

What Traders Need To Know

  • Q2 earnings smashed expectations with EPS of $0.15 vs $0.07 and revenue of $196.6M vs $186.1M, delivering a third straight quarter of 25%+ net revenue growth and 18.6% EBITDA margin.
  • Management raised its FY26 outlook to about 20% revenue growth and lifted the adjusted EBITDA margin target to 14.8%-15% from 13%-13.2%.
  • Shares of FIGS Inc. jumped nearly 28% after the Q2 beat, with strong year-over-year growth and better profitability sparking aggressive buying.
  • Multiple firms, including BTIG, KeyBanc, Barclays, Roth Capital, and Goldman Sachs, raised price targets on FIGS after the report, several reiterating Buy or Overweight ratings.
  • One counterpoint came from Telsey Advisory, which trimmed its target to $16 and kept a Market Perform rating, flagging macro and supply chain risks despite the strong quarter.

Candlestick Chart

Weekly Update Aug 03 – Aug 07, 2026: On Sunday, August 09, 2026 FIGS Inc. stock [NYSE: FIGS] is trending up by 28.71%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Consumer Discretionary industry expert:

Analyst sentiment – positive

FIGS stands as a scaled, profitable niche leader in premium medical apparel, combining DTC DNA with increasingly diversified channels. Revenue of ~$631M with mid‑teens multi‑year CAGR, gross margin of 66.6%, and Q2 EBIT margin above the 6.1% full‑year level underscore strong unit economics. Returns on equity around 10% and ROIC ~6% are healthy for an asset‑light model, while leverage is negligible (D/E 0.14, current ratio 5.4). Free cash flow of ~$44M in Q2 supports continued reinvestment and optionality around capital returns.

Technically, FIGS has shifted decisively into a momentum uptrend. This week’s move from ~$11 to $14.47, with the 8/6 gap and expansion candle on heavy volume, confirms a breakout from a multi‑month base. Intraday 5‑minute action shows persistent dip‑buying above $13.50 with rising volume into the close, signaling strong institutional demand. For traders, $13.80–14.00 is the critical first support; a sustained hold above this zone favors a measured long with a tight stop just below $13.40.

Fundamentally and relative to Consumer Discretionary and Apparel & Luxury peers, FIGS screens as a premium‑multiple growth compounder. Three consecutive quarters of 25%+ net revenue growth, Q2 EPS beat (0.15 vs 0.07), and EBITDA margin expansion to ~18.6% justify its high P/E versus slower‑growing apparel names. Raised FY26 guidance (≈20% revenue growth, higher margin targets) plus multiple Buy‑rated PT hikes support further re‑rating. I see near‑term resistance at $16.50–17 and an achievable 6–12 month target of $20.

Quick Financial Overview

FIGS Inc. delivered a clean beat in Q2, printing $196.6M in revenue versus roughly $186M expected and EPS of $0.15 versus $0.07. That put net revenue growth north of 25% for the third quarter in a row and pushed adjusted EBITDA margin to 18.6%, a strong level for an apparel-focused brand. With gross margin around 66.6% and profit margin in the mid-single digits, the model is clearly built on high product markup and ongoing operating leverage.

From a balance sheet view, FIGS Inc. carries modest leverage, with total debt to equity at 0.14 and a current ratio of 5.4. Cash and short-term investments sit comfortably above $250M, and Q2 free cash flow of about $44.3M shows the brand is converting earnings into cash. Returns on equity and assets are positive and improving, helped by asset turnover of 1.2, which tells traders the business is using its asset base fairly efficiently for a growth story.

On the tape, the Q2 report acted like a reset. Weekly data show FIGS stock grinding near $11 before the release, then exploding to a $14.90 high and holding above $14 into the week’s close. Intraday, price spiked from the low teens to above $16.30 before backing off to the mid-$14s, a classic earnings gap plus run with some profit-taking. With a price-to-sales ratio near 3.6 and a rich P/E near 67.9, the stock is priced for continued growth, which puts extra weight on each future quarter for momentum traders.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:


How much has this post helped you?



Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”